PL3955899T3 - Długotrwale stabilna kompozycja żywej mikrobioty - Google Patents

Długotrwale stabilna kompozycja żywej mikrobioty

Info

Publication number
PL3955899T3
PL3955899T3 PL20716843.6T PL20716843T PL3955899T3 PL 3955899 T3 PL3955899 T3 PL 3955899T3 PL 20716843 T PL20716843 T PL 20716843T PL 3955899 T3 PL3955899 T3 PL 3955899T3
Authority
PL
Poland
Prior art keywords
microbiota
living
long
stable composition
term stable
Prior art date
Application number
PL20716843.6T
Other languages
English (en)
Inventor
Josep M. SUÑÉ NEGRE
Alex SORIANO VILADOMIU
Andrea AIRA GOMEZ
Csaba Feher
Original Assignee
Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS)
Hospital Clínic De Barcelona
Universitat De Barcelona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Hospital Clínic De Barcelona, Universitat De Barcelona filed Critical Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS)
Publication of PL3955899T3 publication Critical patent/PL3955899T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL20716843.6T 2019-04-15 2020-04-14 Długotrwale stabilna kompozycja żywej mikrobioty PL3955899T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19382287 2019-04-15
PCT/EP2020/060370 WO2020212297A1 (en) 2019-04-15 2020-04-14 Long-term stable live fecal microbiota composition

Publications (1)

Publication Number Publication Date
PL3955899T3 true PL3955899T3 (pl) 2025-09-22

Family

ID=66349477

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20716843.6T PL3955899T3 (pl) 2019-04-15 2020-04-14 Długotrwale stabilna kompozycja żywej mikrobioty

Country Status (19)

Country Link
US (3) US20220143107A1 (pl)
EP (2) EP4609873A3 (pl)
JP (1) JP2022529008A (pl)
KR (1) KR20210152505A (pl)
CN (3) CN122163565A (pl)
AU (1) AU2020259740B2 (pl)
BR (1) BR112021020606A2 (pl)
CA (1) CA3130816A1 (pl)
DK (1) DK3955899T3 (pl)
EA (1) EA202192291A1 (pl)
ES (1) ES3035981T3 (pl)
FI (1) FI3955899T3 (pl)
IL (1) IL287238A (pl)
MX (1) MX2021011246A (pl)
PH (1) PH12021552573A1 (pl)
PL (1) PL3955899T3 (pl)
PT (1) PT3955899T (pl)
SG (1) SG11202110641XA (pl)
WO (1) WO2020212297A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2985729C (en) 2015-05-11 2023-05-09 Mybiotics Pharma Ltd Systems and methods for growing a biofilm of probiotic bacteria on solid particles for colonization of bacteria in the gut
KR102380134B1 (ko) 2016-05-25 2022-03-29 마이바이오틱스 파마 엘티디. 미생물총 치료를 위한 조성물 및 방법
EA202192291A1 (ru) 2019-04-15 2022-02-11 Институт Д'Инвестигасьонс Биомедикас Аугуст Пи И Суньер (Идибапс) Композиция, содержащая стабильную в течение длительного времени живую фекальную микробиоту

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1190386A (en) * 1966-06-28 1970-05-06 Green Cross Corp Process for producing the Lactic Acid Bacteria Drugs
FR2708621B1 (fr) * 1993-07-29 1995-10-20 Lesaffre & Cie Biomasse stable à base de cellules de levure et de bactéries lactiques et procédé de préparation.
ITMI20011632A1 (it) * 2001-07-27 2003-01-27 Sanofi Synthelabo Composizione solida contenente spore di batteri non patogeni del genere bacillus
US20050266069A1 (en) 2002-09-06 2005-12-01 Simmons Donald L Stable probiotic microsphere compositions and their methods of preparation
US20050100559A1 (en) 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
GB0330009D0 (en) 2003-12-24 2004-01-28 Ferrosan As Probiotic tablet formulations
SI1928426T1 (sl) 2005-09-29 2015-01-30 Merck Patent Gmbh Postopek za stabiliziranje farmacevtskih oblik za dajanje, ki vsebujejo mikroorganizme
DE102005062731A1 (de) * 2005-12-22 2007-06-28 Organobalance Gmbh Neue Lactobacillus Stämme und deren Verwendung
TR200800634A2 (tr) * 2008-01-30 2009-02-23 Takka Sevgi̇ Uzatılmış salım sağlayan fluvastatin tablet.
US9427012B2 (en) * 2010-08-10 2016-08-30 R.P. Scherer Technologies, Llc Process of manufacturing a stable softgel capsule containing microencapsulated probiotic bacteria
CN104095180A (zh) * 2013-04-12 2014-10-15 中国科学院烟台海岸带研究所 一种益生菌菊粉片及其制备方法
JP6727195B2 (ja) * 2014-10-01 2020-07-22 ７９０５１２２ カナダ インコーポレイテッド 吸水性材料の製造のためのプロセス
WO2016178775A1 (en) * 2015-05-01 2016-11-10 Microbiome Health Research Institute Inc. Compositions and methods for therapeutic delivery of microbial communities
CN104922158B (zh) * 2015-06-05 2018-11-02 中国人民解放军第三军医大学第三附属医院 粪菌胶囊及其制备与应用
US10905726B2 (en) 2015-06-09 2021-02-02 Rebiotix, Inc. Microbiota restoration therapy (MRT) compositions and methods of manufacture
US11091734B2 (en) * 2016-06-30 2021-08-17 Firmenich Sa Plated yeast formulations
WO2018140931A1 (en) * 2017-01-30 2018-08-02 The Board Of Regents Of The University Of Texas System Compositions and methods for fecal microbiota transplantation
EP3675833B1 (en) 2017-08-29 2026-06-10 Chr. Hansen A/S Stable capsules with fecal microbiota or a culture of microorganisms
CN108567799A (zh) * 2018-08-01 2018-09-25 中国人民解放军总医院 一种全粪菌复合胶囊及其制备方法和应用
EA202192291A1 (ru) 2019-04-15 2022-02-11 Институт Д'Инвестигасьонс Биомедикас Аугуст Пи И Суньер (Идибапс) Композиция, содержащая стабильную в течение длительного времени живую фекальную микробиоту

Also Published As

Publication number Publication date
AU2020259740A1 (en) 2021-10-28
CN113710237A (zh) 2021-11-26
EP4609873A2 (en) 2025-09-03
CN122251359A (zh) 2026-06-23
MX2021011246A (es) 2022-01-18
KR20210152505A (ko) 2021-12-15
CN113710237B (zh) 2026-04-03
ES3035981T3 (en) 2025-09-11
SG11202110641XA (en) 2021-10-28
CN122163565A (zh) 2026-06-09
EP3955899A1 (en) 2022-02-23
AU2020259740B2 (en) 2025-12-18
US20240131085A1 (en) 2024-04-25
JP2022529008A (ja) 2022-06-16
US12521422B2 (en) 2026-01-13
WO2020212297A1 (en) 2020-10-22
FI3955899T3 (fi) 2025-07-28
DK3955899T3 (da) 2025-08-04
BR112021020606A2 (pt) 2021-12-07
PT3955899T (pt) 2025-07-18
US20260191917A1 (en) 2026-07-09
PH12021552573A1 (en) 2022-07-04
EP4609873A3 (en) 2025-11-12
CA3130816A1 (en) 2020-10-22
IL287238A (en) 2021-12-01
EA202192291A1 (ru) 2022-02-11
EP3955899B1 (en) 2025-05-07
US20220143107A1 (en) 2022-05-12

Similar Documents

Publication Publication Date Title
IL291933A (en) Oligonucleotide compositions and methods of use thereof
DK3775092T3 (da) Stabiliserede fluoroolefinsammensætninger og fremgangsmåder til fremstilling, oplagring og anvendelse deraf
IL269334A (en) Improved t cell compositions and methods
EP4043002A4 (en) Dental composition
DK3710036T3 (da) Stable ascorbic acid compositions and methods of using the same
JP2018172409A5 (ja) １５−ｈｅｐｅを含む組成物および同組成物を使用する方法
EP3989952A4 (en) Cbd composition
IL281938A (en) Stable semaglutide compositions and uses thereof
EP4028059A4 (en) STABLE MEDICAL CANNABIDIOL COMPOSITIONS
DK3801656T3 (da) Hudkompatibel silikonesammensætning
EP3761945A4 (en) PRESERVATION OF PERSONAL CARE COMPOSITIONS
EP3816266A4 (en) ? -HYDROXYISOBUTYRIC ACID ESTER COMPOUND, COMPOSITION OF A PERFUME SUBSTANCE AND USE AS A PERFUME SUBSTANCE
EP3864058A4 (en) PHOTOCURABLE COMPOSITION
EP4052761A4 (en) PERFUME COMPOSITION
DK3544420T3 (da) Anvendelse af sammensætninger til organ-/vævskonservering
EP4122443A4 (en) Cosmetic composition
DK3955899T3 (da) Langtidsstabil, levende mikrobiotasammensætning
EP3900694A4 (en) TEETH BONDING COMPOSITION
EP3892256A4 (en) COSMETIC COMPOSITION
EP4043962C0 (de) Photopolymerisierbare zusammensetzung
LT3582617T (lt) Pesticidinių piridazinpirazolamidų stabili kompozicija
EP3858322A4 (en) Dental composition
IT201900004805A1 (it) Composizioni antitraspiranti e deodoranti
EP3687483C0 (en) KERATIN FIBERS CARE COMPOSITION
EP4179105A4 (en) COMPOSITIONS COMPRISING ANTIBODIES DIRECTED AGAINST HUMAN IDO-2